Current Value of Holding

$47.5 Million

Shares

1.19 Million

% of Portfolio

0.05%

Average Buy Price

$48.8

Avg closing price
Price range

23 Ken Griffin Apellis Pharmaceuticals Trades

Ken Griffin acquired 293 Thousand Apellis Pharmaceuticals shares worth $11.7 Million. That's 0.01% of their equity portfolio (1051st largest holding). The first Apellis Pharmaceuticals trade was made in Q2 2018. Since then Ken Griffin bought shares 32 more times and sold shares on 24 occasions. The investor's estimated purchase price is $14.7 Million, resulting in a loss of 20%.

Avg closing price
Price range
Increased shares by 316.0% (+901 Thousand shares) Q1 2024
Avg closing price $63.75
Price range $55.39 - $72.47
Increased shares by 1833.4% (+270 Thousand shares) Q4 2023
Avg closing price $50.73
Price range $37.14 - $64.82
Sold 97.2% shares (-514 Thousand shares) Q3 2023
Avg closing price $43.93
Price range $23.65 - $89.22
Increased shares by 203.7% (+355 Thousand shares) Q2 2023
Avg closing price $86.28
Price range $76.68 - $93.31
Increased shares by 3203.5% (+169 Thousand shares) Q1 2023
Avg closing price $57.70
Price range $46.59 - $66.96
Sold 89.1% shares (-42.9 Thousand shares) Q4 2022
Avg closing price $53.04
Price range $43.24 - $61.04
Sold 75.6% shares (-149 Thousand shares) Q3 2022
Avg closing price $59.17
Price range $44.76 - $68.67
Sold 54.0% shares (-232 Thousand shares) Q2 2022
Avg closing price $45.59
Price range $35.07 - $59.21
Sold 55.0% shares (-524 Thousand shares) Q1 2022
Avg closing price $44.15
Price range $35.46 - $54.12
Sold 48.7% shares (-905 Thousand shares) Q4 2021
Avg closing price $39.37
Price range $30.74 - $49.16
Increased shares by 426.4% (+1.51 Million shares) Q3 2021
Avg closing price $56.19
Price range $31.40 - $69.84
Increased shares by 571.7% (+300 Thousand shares) Q2 2021
Avg closing price $51.60
Price range $40.90 - $64.90
Sold 97.6% shares (-2.15 Million shares) Q1 2021
Avg closing price $47.32
Price range $40.80 - $57.39
Increased shares by 60.8% (+832 Thousand shares) Q3 2020
Avg closing price $29.88
Price range $25.89 - $33.66
Increased shares by 86.4% (+635 Thousand shares) Q2 2020
Avg closing price $32.11
Price range $24.80 - $38.49
Increased shares by 32.1% (+178 Thousand shares) Q1 2020
Avg closing price $35.50
Price range $17.91 - $44.33
New holding (+556 Thousand shares) Q4 2019
Avg closing price $27.68
Price range $22.10 - $30.80
Sold -642 Thousand shares Q3 2019
Avg closing price $27.52
Price range $24.09 - $32.18
Sold 32.1% shares (-303 Thousand shares) Q2 2019
Avg closing price $20.35
Price range $18.00 - $25.34
Increased shares by 1780.3% (+895 Thousand shares) Q1 2019
Avg closing price $15.73
Price range $12.81 - $19.82

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!